Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

@article{Whitlock2012AntithromboticAT,
  title={Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.},
  author={Richard P. Whitlock and Jack C. J. Sun and Stephen E. Fremes and Fraser Douglas Rubens and Kevin Hong To Teoh},
  journal={Chest},
  year={2012},
  volume={141 2 Suppl},
  pages={e576S-e600S}
}
BACKGROUND Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. METHODS The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines. Antithrombotic Therapy and Prevention of… CONTINUE READING